[Tuberculosis in the Czech Republic during 2006].

Cas Lek Cesk

I. klinika tuberkulózy a respiracních nemocí 1. LF UK a VFN, Praha.

Published: January 2008

Background: In the Czech Republic the number of all notified tuberculosis cases decreased in the year 2006. 973 (9.5/100,000) all tuberculosis cases of new diseases and relapses were reported. 799 cases (7.8/100,000) were pulmonary tuberculosis and from them 556 cases (5.5/100,000) were definite pulmonary tuberculosis. In 2006 267 cases of smear positive pulmonary tuberculosis were detected. The decrease in tuberculosis notification rate reported in the Czech Republic since 1998 has continued.

Methods And Results: The resistance for antituberculotic drugs was 7.4% and MDR-TB cases were detected in 1.4% of all bacteriologically confirmed cases. The low level of resistance, good treatment constitutes presumption of further decline in tuberculosis in the Czech Republic.

Conclusions: The majority of tuberculosis cases were diagnosed because of symptoms (74.7%)-passive case-finding. By active case-finding only 11.7% of new pulmonary tuberculosis were detected. In Prague only 6.7% of all pulmonary tuberculosis cases were diagnosed by active case-finding. Next target of tuberculosis control in the Czech Republic will be to increase the percentage of active case-finding in high-risk groups and to monitor latent tuberculosis infection in our population.

Download full-text PDF

Source

Publication Analysis

Top Keywords

pulmonary tuberculosis
20
czech republic
16
tuberculosis cases
16
tuberculosis
12
active case-finding
12
cases
9
tuberculosis detected
8
cases diagnosed
8
pulmonary
5
[tuberculosis czech
4

Similar Publications

Background: Using artificial intelligence (AI) to interpret chest X-rays (CXRs) could support accessible triage tests for active pulmonary tuberculosis (TB) in resource-constrained settings.

Methods: The performance of two cloud-based CXR AI systems - one to detect TB and the other to detect CXR abnormalities - in a population with a high TB and human immunodeficiency virus (HIV) burden was evaluated. We recruited 1978 adults who had TB symptoms, were close contacts of known TB patients, or were newly diagnosed with HIV at three clinical sites.

View Article and Find Full Text PDF

Pulmonary arteriovenous malformation (PAVM) is a congenital vascular pathology, which is caused by the presence of a direct connection between the branches of the artery and the veins of the lungs, and the discharge of unoxygenated blood into the arterial bed. Arteriovenous malformations are characterized by a wide variety of clinical manifestations and, in some cases, may be accompanied with severe circulatory disorders.

View Article and Find Full Text PDF

Objective: This study aimed to enhance the prevention and control of pulmonary tuberculosis (PTB) and provide more effective and accurate methods in Changshu City.

Methods: The PTB patients' information came from the China Information System for Disease Control and Prevention (CISDCP). The demographic data for Changshu city and towns came from the Suzhou Statistical Yearbook and the LandScan platform.

View Article and Find Full Text PDF

A major challenge in tuberculosis (TB) therapeutics is that antibiotic exposure leads to changes in the physiology of (), which may enable the pathogen to withstand treatment. While antibiotic-treated has been evaluated in experiments it is unclear if and how long-term treatment with diverse antibiotics with varying treatment-shortening activity (sterilizing activity) affects physiologic processes differently. Here, we used SEARCH-TB, a pathogen-targeted RNA-sequencing platform, to characterize the transcriptome in the BALB/c high-dose aerosol infection mouse model following 4 weeks of treatment with three sterilizing and three non-sterilizing antibiotics.

View Article and Find Full Text PDF

The impact of heteroresistance on tuberculosis (TB) treatment outcomes is unclear, as is the role of different rifampin and isoniazid exposures on developing resistance mutations. Hollow fiber system model of TB (HFS-TB) units were inoculated with drug-susceptible () and treated with isoniazid and rifampin exposure identified in a clinical trial as leading to treatment failure and acquired drug resistance. Systems were sampled for drug concentration measurements, estimation of total and drug-resistant , and small molecule overlapping reads (SMOR) analysis for the detection of heteroresistance.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!